Literature DB >> 23908295

Complete Genome Sequence of Persistent Cystic Fibrosis Isolate Pseudomonas aeruginosa Strain RP73.

Julie Jeukens1, Brian Boyle, Irene Bianconi, Irena Kukavica-Ibrulj, Burkhard Tümmler, Alessandra Bragonzi, Roger C Levesque.   

Abstract

Pseudomonas aeruginosa can establish lifelong chronic airway infections in cystic fibrosis (CF) patients. However, the genetic features associated with long-term persistence in the lung are not understood. We sequenced the genome of P. aeruginosa strain RP73, which was isolated after 16.9 years of chronic lung infection in a CF patient.

Entities:  

Year:  2013        PMID: 23908295      PMCID: PMC3731849          DOI: 10.1128/genomeA.00568-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The Gram-negative bacterium Pseudomonas aeruginosa is a clinically relevant opportunistic pathogen highly resistant to most classes of antibiotics (1). It is the leading cause of chronic long-term lung infections and death in cystic fibrosis (CF) individuals. Following an initial period of intermittent and acute infections, P. aeruginosa establishes a persistent lifestyle in CF airways (2). Long-term colonization of the host is maintained by patho-adaptive lineages, which are presumably clonal from the initially acquired strain (3). Adaptive and loss-of-function mutations are frequent in virulence genes, which are essential for the initiation of infection and transient-to-long-term persistence in CF airways (4, 5). We selected the multidrug resistant nonmucoid P. aeruginosa strain RP73 as a model to investigate the genomic basis for long-term persistence in CF lung infections. RP73 was isolated 16.9 years after the onset of infection in a CF patient from the Hannover cohort (6). RP73 can establish and maintain long-term lung infection in a murine model of chronic pneumonia (7–9) with histopathological lesions similar to those found in CF patients (10). Hence, this strain is particularly well suited for comparative genomics with other CF strains, the study of P. aeruginosa pathogenesis, and the evaluation of novel antimicrobial therapies. Following isolation, strain RP73 was stored at –80°C in Tryptic soy broth (TSB) with 30% glycerol. Genomic DNA was isolated from an overnight culture using the DNeasy blood and tissue kit (Qiagen). Whole-genome shotgun DNA sequencing was performed using the Roche 454 pyrosequencing method on the Genome Sequencer FLX system with titanium chemistry at the Plateforme d’analyses génomiques of the Institut de Biologie Intégrative et des Systèmes (Université Laval). In total, 319,835,813 nucleotides were analyzed using the gsAssembler module of Newbler v2.5.3. A total of 68 contigs were produced; 40 were larger than 500 nucleotides. Genome finishing was performed using Consed v. 20 (11). Automated annotation was performed with xbase (12) and the NCBI Prokaryotic Genome Annotation Pipeline (PGAAP) using P. aeruginosa PAO1 as a reference genome. The assembled RP73 genome consists of a single circular chromosome of 6,342,034 bp with an average G+C content of 66.5%, which is consistent with previously sequenced P. aeruginosa strains. It contains 6,052 putative genes (5,975 open reading frames [ORFs] and 77 RNA genes). Twelve genomic islands were predicted by IslandViewer analysis (13). Three of the genomic regions carrying putative islands distinguish RP73 from other P. aeruginosa reference genomes and correspond to regions of genome plasticity (14). Namely, the RP73 genome contains PAGI-9 (15) and plasmid pKLC102, which carries the pil gene cluster and chvB glucan synthetase (14). The RP73 genome also contains LESGI-4, which was identified in the Liverpool epidemic strain (16). More detailed analyses of the RP73 genome, including comparative analysis with other P. aeruginosa strains and identification of virulence factor-associated mutations, are in progress.

Nucleotide sequence accession number.

The complete RP73 genome sequence and annotation have been deposited at CCBJ/EMBL/GenBank under the accession number CP006245.1.
  15 in total

1.  Consed: a graphical tool for sequence finishing.

Authors:  D Gordon; C Abajian; P Green
Journal:  Genome Res       Date:  1998-03       Impact factor: 9.043

2.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

3.  The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa.

Authors:  Federica Moalli; Moira Paroni; Tania Véliz Rodriguez; Federica Riva; Nadia Polentarutti; Barbara Bottazzi; Sonia Valentino; Stefano Mantero; Manuela Nebuloni; Alberto Mantovani; Alessandra Bragonzi; Cecilia Garlanda
Journal:  J Immunol       Date:  2011-03-25       Impact factor: 5.422

4.  Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.

Authors:  J L Burns; R L Gibson; S McNamara; D Yim; J Emerson; M Rosenfeld; P Hiatt; K McCoy; R Castile; A L Smith; B W Ramsey
Journal:  J Infect Dis       Date:  2000-12-27       Impact factor: 5.226

Review 5.  Cystic fibrosis and other respiratory diseases of impaired mucus clearance.

Authors:  Alessandra Livraghi; Scott H Randell
Journal:  Toxicol Pathol       Date:  2007-01       Impact factor: 1.902

6.  Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa.

Authors:  Craig Winstanley; Morgan G I Langille; Joanne L Fothergill; Irena Kukavica-Ibrulj; Catherine Paradis-Bleau; François Sanschagrin; Nicholas R Thomson; Geoff L Winsor; Michael A Quail; Nicola Lennard; Alexandra Bignell; Louise Clarke; Kathy Seeger; David Saunders; David Harris; Julian Parkhill; Robert E W Hancock; Fiona S L Brinkman; Roger C Levesque
Journal:  Genome Res       Date:  2008-12-01       Impact factor: 9.043

7.  Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.

Authors:  Alessandra Bragonzi; Moira Paroni; Alessandro Nonis; Nina Cramer; Sara Montanari; Joanna Rejman; Clelia Di Serio; Gerd Döring; Burkhard Tümmler
Journal:  Am J Respir Crit Care Med       Date:  2009-05-07       Impact factor: 21.405

8.  Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy.

Authors:  Moira Paroni; Federica Moalli; Manuela Nebuloni; Fabio Pasqualini; Tracey Bonfield; Alessandro Nonis; Alberto Mantovani; Cecilia Garlanda; Alessandra Bragonzi
Journal:  J Infect Dis       Date:  2012-10-18       Impact factor: 5.226

9.  Genomic islands of Pseudomonas aeruginosa.

Authors:  Scott E Battle; Jordi Rello; Alan R Hauser
Journal:  FEMS Microbiol Lett       Date:  2008-11-18       Impact factor: 2.742

10.  IslandViewer: an integrated interface for computational identification and visualization of genomic islands.

Authors:  Morgan G I Langille; Fiona S L Brinkman
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

View more
  16 in total

1.  Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.

Authors:  Timothy J Bensman; Jordanna G Jayne; Meiling Sun; Elza Kimura; Joshua Meinert; Joshua C Wang; Justin B Schaal; Dat Tran; Adupa P Rao; Omid Akbari; Michael E Selsted; Paul M Beringer
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

2.  Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.

Authors:  Flaviana Di Lorenzo; Łukasz Kubik; Alja Oblak; Nicola Ivan Lorè; Cristina Cigana; Rosa Lanzetta; Michelangelo Parrilli; Mohamad A Hamad; Anthony De Soyza; Alba Silipo; Roman Jerala; Alessandra Bragonzi; Miguel A Valvano; Sonsoles Martín-Santamaría; Antonio Molinaro
Journal:  J Biol Chem       Date:  2015-07-09       Impact factor: 5.157

3.  What It Takes to Be a Pseudomonas aeruginosa? The Core Genome of the Opportunistic Pathogen Updated.

Authors:  Benoît Valot; Christophe Guyeux; Julien Yves Rolland; Kamel Mazouzi; Xavier Bertrand; Didier Hocquet
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

4.  Comparative genomics and biological characterization of sequential Pseudomonas aeruginosa isolates from persistent airways infection.

Authors:  Irene Bianconi; Julie Jeukens; Luca Freschi; Beatriz Alcalá-Franco; Marcella Facchini; Brian Boyle; Antonio Molinaro; Irena Kukavica-Ibrulj; Burkhard Tümmler; Roger C Levesque; Alessandra Bragonzi
Journal:  BMC Genomics       Date:  2015-12-29       Impact factor: 3.969

5.  Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients.

Authors:  Julie Jeukens; Brian Boyle; Irena Kukavica-Ibrulj; Myriam M Ouellet; Shawn D Aaron; Steve J Charette; Joanne L Fothergill; Nicholas P Tucker; Craig Winstanley; Roger C Levesque
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

6.  Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment.

Authors:  Céline Lucchetti-Miganeh; David Redelberger; Gaël Chambonnier; François Rechenmann; Sylvie Elsen; Christophe Bordi; Katy Jeannot; Ina Attrée; Patrick Plésiat; Sophie de Bentzmann
Journal:  Pathogens       Date:  2014-04-10

Review 7.  Advances in understanding Pseudomonas.

Authors:  Burkhard Tümmler; Lutz Wiehlmann; Jens Klockgether; Nina Cramer
Journal:  F1000Prime Rep       Date:  2014-02-03

8.  Pseudomonas aeruginosa clinical and environmental isolates constitute a single population with high phenotypic diversity.

Authors:  María-Victoria Grosso-Becerra; Christian Santos-Medellín; Abigail González-Valdez; José-Luis Méndez; Gabriela Delgado; Rosario Morales-Espinosa; Luis Servín-González; Luis-David Alcaraz; Gloria Soberón-Chávez
Journal:  BMC Genomics       Date:  2014-04-28       Impact factor: 3.969

9.  A novel signal transduction pathway that modulates rhl quorum sensing and bacterial virulence in Pseudomonas aeruginosa.

Authors:  Qiao Cao; Yue Wang; Feifei Chen; Yongjie Xia; Jingyu Lou; Xue Zhang; Nana Yang; Xiaoxu Sun; Qin Zhang; Chao Zhuo; Xi Huang; Xin Deng; Cai-Guang Yang; Yan Ye; Jing Zhao; Min Wu; Lefu Lan
Journal:  PLoS Pathog       Date:  2014-08-28       Impact factor: 6.823

10.  Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis.

Authors:  Anna Sze Tai; Scott Cameron Bell; Timothy James Kidd; Ella Trembizki; Cameron Buckley; Kay Annette Ramsay; Michael David; Claire Elizabeth Wainwright; Keith Grimwood; David Mark Whiley
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.